BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32919882)

  • 1. Double filtration plasmapheresis - 10-year pediatric experience as an alternative to plasma exchange.
    Maxted AP; Connell R; Hussain F
    Transfus Apher Sci; 2020 Dec; 59(6):102928. PubMed ID: 32919882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
    Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
    J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.
    Paglialonga F; Schmitt CP; Shroff R; Vondrak K; Aufricht C; Watson AR; Ariceta G; Fischbach M; Klaus G; Holtta T; Bakkaloglu SA; Zurowska A; Jankauskiene A; Vande Walle J; Schaefer B; Wright E; Connell R; Edefonti A
    Pediatr Nephrol; 2015 Jan; 30(1):103-11. PubMed ID: 25135618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
    Sawada T; Fuchinoue S; Teraoka S
    Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
    Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
    Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
    Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
    J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
    Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
    BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
    Lyu RK; Chen WH; Hsieh ST
    Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal segmental glomerulosclerosis after renal transplantation in a child with ANCA-associated glomerulonephritis: case report and literature review].
    Rong LP; Chen LZ; Fu Q; Chen WF; Sun LZ; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):936-940. PubMed ID: 27938596
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
    Chen WH; Yeh JH; Chiu HC
    J Clin Apher; 1999; 14(3):126-9. PubMed ID: 10540367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
    Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
    Tagawa Y; Yuki N; Hirata K
    Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
    Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
    Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
    Tagawa Y; Yuki N; Hirata K
    J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.